NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Cash from operating activities improves to positive | A primary condition in Natural Alternatives International Inc's published investment case. The stated target is >= $2.5M. | Broken | cash from operating activities falls below $0 | Cash from operations: $6.302M FY2025-Q4; GAAP. Published target: >= $2.5M. The stored target says 2026-Q3; this source reports FY2025-Q4. Fiscal/calendar alignment needs review. Source published Sep 28, 20266,302,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2025-Q4 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2025-Q4. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of last 3 quarters. Cash from operating activities improved from -$6.33M in 2026-Q2 to $2.50M in 2026-Q3, indicating progress towards stabilizing financial performance. The trajectory shows delivering on this priority. Delivery assessment Jul 30, 2026 |
Gross profit improves from recent lows | A supporting condition in Natural Alternatives International Inc's published investment case. The stated target is gross profit >= $0.38M. | Intact | gross profit falls below $0.3M | Gross profit: $383,000 FY2026-Q3; GAAP. Published target: gross profit >= $0.38M. The target does not explicitly identify fiscal versus calendar quarters. Source published May 19, 2026383,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Mar 31, 2026 Source: company_financial_results. Reference: e43fe431-4002-4493-b84b-7de3f5775aa7. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of last 3 quarters. Gross profit decreased from $2.49M in 2026-Q2 to $0.38M in 2026-Q3, showing limited progress in enhancing margins. The trajectory indicates challenges in achieving this priority. Delivery assessment Jul 30, 2026 |
Net income moves toward profitability | A primary condition in Natural Alternatives International Inc's published investment case. The stated target is net income improves toward >= $0. | Broken | net income worsens or stays below -$4M | Net income: $-4.311M FY2026-Q3; GAAP. Published target: net income improves toward >= $0. Target period is not explicitly aligned with this observation. Source published May 19, 2026-4,311,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending Mar 31, 2026 Source: company_financial_results. Reference: e43fe431-4002-4493-b84b-7de3f5775aa7. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of last 3 quarters. Despite efforts, net income declined from -$2.55M in 2026-Q2 to -$4.31M in 2026-Q3, indicating limited progress towards profitability. The trajectory shows challenges in achieving this priority. Delivery assessment Jul 30, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business rather than an established compounder. Its thesis is on watch, with the recent signal moving from cautious to mixed, but execution has not yet shown consistent progress toward profitability.
The evidence describes NAII as cheap versus peers, while also showing a small premium versus peers and a large negative expectations gap. The valuation model has low confidence, so the picture is uncertain; the snapshot does not indicate that weak results are already fully reflected in expectations.
Near term, operating cash flow improved from negative in 2026-Q2 to positive in 2026-Q3, but net losses widened and gross profit fell over the same period. The next results carry elevated miss risk, and a guidance cut would be a meaningful negative; management’s stated priorities show progress in cash flow but mixed results on profitability and margins.
Over the multi-year view, the key question is whether better operating cash flow can continue and translate into sustained profitability and stronger gross profit. Near term, guidance and results are major swing factors, while weaker employment data could weigh on cyclical businesses and stronger results from sector peers could support sector momentum.
For the next 1 to 3 years, the thesis is a high-risk recovery case with early cash-flow progress but unresolved profitability and margin challenges. Evidence is limited and the valuation signal is uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.